Immediate Impact
11 standout
Citing Papers
Deep Learning in Breast Cancer Imaging: A Decade of Progress and Future Directions
2024 Standout
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
2024 Standout
Works of Minyi Cheng being referenced
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple‐negative , early‐stage breast cancer (NeoCART ): Results from a multicenter, randomized controlled, open‐label phase II trial
2021
Multiparametric MRI-based radiomics analysis for the prediction of breast tumor regression patterns after neoadjuvant chemotherapy
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Minyi Cheng | 157 | 177 | 76 | 130 | 37 | 384 | |
| Mei Yang | 180 | 189 | 96 | 112 | 34 | 430 | |
| R. Jared Weinfurtner | 175 | 121 | 106 | 132 | 33 | 415 | |
| Benedikt Schaefgen | 136 | 281 | 212 | 129 | 23 | 421 | |
| Joanna Niemiec | 238 | 132 | 72 | 123 | 44 | 453 | |
| M. Boisserie-Lacroix | 121 | 165 | 208 | 135 | 45 | 429 | |
| Milim Kim | 173 | 122 | 73 | 74 | 26 | 363 | |
| Amro Masarwah | 69 | 157 | 116 | 207 | 25 | 435 | |
| Yanjun Hou | 260 | 118 | 46 | 129 | 29 | 421 | |
| Jingming Ye | 195 | 189 | 87 | 99 | 55 | 362 | |
| Tanya W. Moseley | 109 | 229 | 178 | 100 | 36 | 350 |
All Works
Login with ORCID to disown or claim papers
Loading papers...